AMERIPRISE FINANCIAL INC
For the period ended Dec 31, 2023. Filed Feb 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 22, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Market Risk Benefits
- Market Risk Benefits
Market risk benefits are contracts or contract features that both provide protection to the contractholder from other-than-nominal capital market risk and expose the Company to other-than-nominal capital market risk. Most of the variable annuity contracts issued by the Company contain a GMDB provision. The Company previously offered contracts containing GMWB, GMAB, or GMIB provisions.
The GMDB provisions provide a specified minimum return upon death of the contractholder. The death benefit payable is the greater of (i) the contract value less any purchase payment credits subject to recapture less a pro-rata portion of any rider fees, or (ii) the GMDB provisions specified in the contract. The Company has the following primary GMDB provisions:
Return of premium – provides purchase payments minus adjusted partial surrenders.
Reset – provides that the value resets to the account value at specified contract anniversary intervals minus adjusted partial surrenders. This provision was often provided in combination with the return of premium provision and is no longer offered.
Ratchet – provides that the value ratchets up to the maximum account value at specified anniversary intervals, plus subsequent purchase payments less adjusted partial surrenders.
The variable annuity contracts with GMWB riders typically have account values that are based on an underlying portfolio of mutual funds, the values of which fluctuate based on fund performance. At contract issue, the guaranteed amount is equal to the amount deposited but the guarantee may be increased annually to the account value (a “step-up”) in the case of favorable market performance or by a benefit credit if the contract includes this provision.
Index
The Company has GMWB riders in force, which contain one or more of the following provisions:
Withdrawals at a specified rate per year until the amount withdrawn is equal to the guaranteed amount.
Withdrawals at a specified rate per year for the life of the contractholder (“GMWB for life”).
Withdrawals at a specified rate per year for joint contractholders while either is alive.
Withdrawals based on performance of the contract.
Withdrawals based on the age withdrawals begin.
Credits are applied annually for a specified number of years to increase the guaranteed amount as long as withdrawals have not been taken.
Variable annuity contractholders age 79 or younger at contract issue could obtain a principal-back guarantee by purchasing the optional GMAB rider for an additional charge. The GMAB rider guarantees that, regardless of market performance at the end of the 10-year waiting period, the contract value will be no less than the original investment or a specified percentage of the highest anniversary value, adjusted for withdrawals. If the contract value is less than the guarantee at the end of the 10-year period, a lump sum will be added to the contract value to make the contract value equal to the guarantee value.
Individual variable annuity contracts may have both a death benefit and a living benefit. Net amount at risk is quantified for each benefit and a composite net amount at risk is calculated using the greater of the death benefit or living benefit for each individual contract. The net amount at risk for GMDB and GMAB is defined as the current guaranteed benefit amount in excess of the current contract value. The net amount at risk for GMIB is defined as the greater of the present value of the minimum guaranteed annuity payments less the current contract value or zero. The net amount at risk for GMWB is defined as the greater of the present value of the minimum guaranteed withdrawal payments less the current contract value or zero.
The following tables summarize the balances of and changes in market risk benefits, including the January 1, 2021 adoption of ASU 2018-12:
| (in millions) | |
|---|---|
| Pre-adoption balance at December 31, 2020 | $3,084 |
| Effect of shadow reserve adjustments | (3) |
| Adjustments for the cumulative effect of the changes in instrument-specific credit risk on market risk benefits between the original contract issuance date and the transition date | 670 |
| Adjustments to the host contract for differences between previous carrying amount and fair value measurement for the market risk benefits under the option-based method of valuation | 20 |
| Adjustments for the remaining difference (exclusive of the instrument-specific credit risk change and host contract adjustments) between previous carrying amount and fair value measurements for the market risk benefits | 1,058 |
| Post-adoption balance at January 1, 2021 | $4,829 |
Index
| Years Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| (in millions, except age) | |||
| Balance at beginning of period | $1,103 | $2,901 | $4,829 |
| Issuances | 17 | 27 | 45 |
| Interest accrual and time decay | (53) | (237) | (294) |
| Reserve increase from attributed fees collected | 788 | 810 | 819 |
| Reserve release for benefit payments and derecognition | (35) | (29) | (8) |
| Effect of changes in interest rates and bond markets | (367) | (4,193) | (1,053) |
| Effect of changes in equity markets and subaccount performance | (1,267) | 2,258 | (1,558) |
| Effect of changes in equity index volatility | (67) | 205 | 73 |
| Actual policyholder behavior different from expected behavior | 5 | 17 | 52 |
| Effect of changes in other future expected assumptions | 128 | (139) | 123 |
| Effect of changes in the instrument-specific credit risk on market risk benefits | 83 | (517) | (127) |
| Balance at end of period | $335 | $1,103 | $2,901 |
| Reconciliation of the gross balances in an asset or liability position: | |||
| Asset position | $1,427 | $1,015 | $539 |
| Liability position | (1,762) | (2,118) | (3,440) |
| Net asset (liability) position | $(335) | $(1,103) | $(2,901) |
| Guaranteed benefit amount in excess of current account balances (net amount at risk): | |||
| Death benefits | $913 | $2,781 | $251 |
| Living benefits | $2,513 | $3,364 | $195 |
| Composite (greater of) | $3,308 | $5,830 | $441 |
| Weighted average attained age of contractholders | 69 | 68 | 68 |
| Changes in unrealized (gains) losses in net income relating to liabilities held at end of period | $(1,551) | $(2,044) | $(2,502) |
| Changes in unrealized (gains) losses in other comprehensive income relating to liabilities held at end of period | $84 | $(505) | $(102) |
The following tables provide a summary of the significant inputs and assumptions used in the fair value measurements developed by the Company or reasonably available to the Company of market risk benefits:
| December 31, 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Fair Value · Valuation Technique · Significant Inputs and Assumptions · Range · Weighted Average | ||||||||
| (in millions) | ||||||||
| Market risk benefits | $335 | Discounted cash flow | Utilization of guaranteed withdrawals (1) | 0.0% | – | 48.0% | 11.6% | |
| Surrender rate (2) | 0.3% | – | 75.0% | 3.7% | ||||
| Market volatility (3) | 0.0% | – | 25.2% | 10.6% | ||||
| Nonperformance risk (4) · 85 bps · 85 bps | ||||||||
| Mortality rate (5) | 0.0% | – | 41.6% | 1.6% | ||||
Index
| December 31, 2022 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Fair Value · Valuation Technique · Significant Inputs and Assumptions · Range · Weighted Average | ||||||||
| (in millions) | ||||||||
| Market risk benefits | $1,103 | Discounted cash flow | Utilization of guaranteed withdrawals (1) | 0.0% | – | 48.0% | 11.0% | |
| Surrender rate (2) | 0.2% | – | 45.6% | 3.6% | ||||
| Market volatility (3) | 0.0% | – | 26.6% | 12.1% | ||||
| Nonperformance risk (4) · 95 bps · 95 bps | ||||||||
| Mortality rate (5) | 0.0% | – | 41.6% | 1.5% | ||||
(1) The utilization of guaranteed withdrawals represents the percentage of contractholders that will begin withdrawing in any given year. The weighted average utilization rate represents the average assumption, weighted based on the benefit base. The calculation excludes policies that have already started taking withdrawals.
(2)The weighted average surrender rate represents the average assumption weighted based on the account value of each contract.
(3) Market volatility represents the implied volatility of each contractholder’s mix of funds. The weighted average market volatility represents the average volatility across all contracts, weighted by the size of the guaranteed benefit.
(4) The nonperformance risk is the spread added to the U.S. Treasury curve.
(5) The weighted average mortality rate represents the average assumption weighted based on the account value of each contract.
Changes to Significant Inputs and Assumptions:
During the years ended December 31, 2023 and 2022, the Company updated inputs and assumptions based on management’s review of experience studies. These updates resulted in the following notable changes in the fair value estimates of market risk benefits calculations:
Year ended December 31, 2023
Updates to utilization of guaranteed withdrawals assumptions resulted in a decrease to pre-tax income of $18 million.
Updates to surrender assumptions resulted in a decrease to pre-tax income of $110 million.
Year ended December 31, 2022
Updates to utilization of guaranteed withdrawals assumptions resulted in a decrease to pre-tax income of $39 million.
Updates to surrender assumptions resulted in a decrease to pre-tax income of $200 million.
Updates to mortality assumptions resulted in a decrease to pre-tax income of $49 million.
Refer to the rollforward of market risk benefits for the impacts of changes to interest rate, equity market, volatility and nonperformance risk assumptions.
Uncertainty of Fair Value Measurements
Significant increases (decreases) in utilization and volatility used in the fair value measurement of market risk benefits in isolation would have resulted in a significantly higher (lower) liability value.
Significant increases (decreases) in nonperformance risk and surrender assumptions used in the fair value measurement of market risk benefits in isolation would have resulted in a significantly lower (higher) liability value.
Significant increases (decreases) in mortality assumptions used in the fair value measurement of the death benefit portion of market risk benefits in isolation would have resulted in a significantly higher (lower) liability value whereas significant increases (decreases) in mortality rates used in the fair values measurement of the life contingent portion of market risk benefits in isolation would have resulted in a significantly lower (higher) liability value.
Surrender assumptions, utilization assumptions and mortality assumptions vary with the type of base product, type of rider, duration of the policy, age of the contractholder, calender year of the projection, previous withdrawal history, and the relationship between the value of the guaranteed benefit and the contract accumulation value.
The Company values market risk benefits using internal valuation models. These models include observable capital market assumptions and significant unobservable inputs related to implied volatility as well as contractholder behavior assumptions that include margins for risk, all of which the Company believes a market participant would expect. The fair value also reflects a current estimate of the Company’s nonperformance risk. Given the significant unobservable inputs to this valuation, these measurements are classified as Level 3.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.